微芯生物向特定对象发行股票申请获得证监会同意注册批复

Core Viewpoint - Microchip Biotech (688321) has received approval from the China Securities Regulatory Commission for its stock issuance to specific investors, aiming to raise up to 950 million yuan for various projects [1] Group 1: Stock Issuance - The company plans to issue stocks to specific investors with a total fundraising amount not exceeding 950 million yuan, including the principal [1] - The net proceeds from the fundraising, after deducting related issuance costs, will be allocated to innovative drug research and development projects, the first phase of the Pengzhou Microchip original drug manufacturing base project, and to supplement working capital [1]